Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Schroders Capital Private Equity Uk Innovation S.C.S. investment portfolio
Schroders Capital Private Equity Uk Innovation S.C.S. has made numerous investments in companies such as Luminance Technologies, Artios Pharma, and Draig Therapeutics within the AI sector.
vc
Portfolio
4
Team
0
Portfolio (4)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Artios Pharma Limited Artios Pharma Limited develops DNA‑damage‑response‑based cancer therapeutics. Its pipeline includes the ATR inhibitor alnodesertib and the Polθ inhibitor ART6043, targeting hard‑to‑treat solid tumours. | Healthcare & Life Sciences | Cambridge | Confirmed | 2025-12-28 |
| Draig Therapeutics Ltd Draig Therapeutics develops clinical‑stage neuropsychiatric therapies designed to restore brain health and treat neuropsychiatric diseases. Its focus is on delivering transformative treatments for patients with these conditions. | BiotechHealth Tech | Cardiff | Confirmed | 2025-05-17 |
Shareholding changes (4)
Schroders Capital Private Equity Uk Innovation S.C.S.'s positions across portfolio companies2026
- SERIES B-2 0 → 40,287
- SERIES A1 0 → 658,490
Articles (5)
- 16 Jul 2026
- 27 Jun 2026
- 25 May 2026
- Luminance Technologies secures £76.2k following major growth rounds13 May 2026Luminance Technologies
- Cardiff biotech Draig Therapeutics secures £34.6m Series A for neuropsychiatric pipeline12 May 2026Draig Therapeutics